New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2014
07:51 EDTNLNKNewLink Genetics price target raised to $40 from $23 at RW Baird
Baird raised its price target on NewLink Genetics on expectations of a fairly strong and aggressive uptake of IDO-inhibitor indoximod for many types of cancer. Shares are Outperform rated.
News For NLNK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for NLNK

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use